biomarkers Related Content

A group of researchers around the globe have created a portable, non-invasive device capable of identifying biomarkers associated with Alzheimer's and Parkinson's disease.

New research reveals a wearable night headband capable of identifying early biomarkers for Alzheimer's disease in asymptomatic adults.

Researchers are developing a new Alzheimer's disease detection sensor that can be used in the early stages of Alzheimers and a number of other diseases.

Eric Buckland of Translational Imaging Innovations and Ronald Schuchard, Clinical Product Development Expert, explore the benefits of ophthalmic precision medicine to improve patient care across sectors.

Novel smart insole solution helps people with diabetes ensure foot health, by preventing peripheral neuropathy ulcers and falls.

Dr. Irene van Kamp, from the National Institute for Public Health and the Environment, discusses the exposome concept to study the role of the environment in human disease.

Dr Quinton Fivelman, Chief Scientific Officer at London Medical Laboratory, says fighting near Ukraine’s nuclear power facilities brings home the need for a rapid radiation blood test.

Dr. Shivani Amdekar, Medical Director at Oxford Immune Algorithmics, believes deep immune monitoring could be the key to creating a Long COVID test.

New tech has helped confirm that the destruction of brain synapses underlies the cognitive deficits experienced by patients with Alzheimer’s

Dr Jeanine Houwing-Duistermaat (statistics) and Dr Gastone Castellani (biophysics) from the University of Bologna, Italy, organised innovative interdisciplinary training in multi-omics research within the IMforFUTURE project, which focused on communication between wet and dry lab.

Researching DNA outside of our genes, analysing the ‘dark genome’, scientists have found evolved proteins which can distinguish between schizophrenia and bipolar disorders, improving diagnosis and treatment.

Researchers at the University of Chicago are believed to be one step closer in the development of blood tests to identify depression.

A new study has uncovered a gene that links severe COVID and Alzheimer's, via "immune system changes" that can happen in both conditions.

Open Access Government spoke to Dr Robyn S. Klein, MD, PhD, about her ground-breaking work in neuroimmunology and the path to understanding the links between viral encephalitis and memory disorders.

Study suggests that long COVID patients are more likely to face blood-clots - even if they appeared okay, their clotting biomarkers were significantly high.

The team at Baylor College of Medicine are combining machine learning with a blood test, to hopefully reveal markers of early schizophrenia.

A new study by the University of Eastern Finland finds that a blood test could help to diagnose patients with frontotemporal dementia.

Dr Rutger Zietsma – CEO at Manus Neurodynamica Ltd – and PD Dr Angela Deutschländer share their vision on earlier diagnosis and objective symptom tracking with the NeuroMotor PenTM.

Richie Kohman, Synthetic Biology Platform Lead, Wyss Institute at Harvard, tells us all about Next Generation Sequencing in analysing synthetic biology signatures in brain tissue.

Researchers believe that they have found a PTSD marker in the brain region associated with emotional regulation - with the marker being strongest in people with "impaired executive dysfunction".